Navigating the Complexities of Early Drug Development
This infographic provides industry professionals and senior scientists with insights into detailed methodologies for addressing stability challenges in protein therapeutics. Learn about advanced analytical techniques and their practical applications in improving drug development.
Download this complimentary digest today!
What you will learn about:
- Understanding the significance of clone characterization in early drug development.
- Utilizing CE-SDS for assessing cell line purity and charge variant monitoring.
- Integrating icIEF-UV/MS workflows for rapid charge variant identification.
- Strategies for efficient cell line screening and resource management to reduce risk.
More Information
The journey from concept to therapeutic involves rigorous scientific and logistical milestones. This digest highlights the importance of clone characterization and critical quality attribute verification in early drug development. Analytical assays like CE-SDS and icIEF-UV/MS are pivotal in ensuring protein purity and identifying charge variants. By addressing key challenges in cell line screening and resource management, researchers can streamline development timelines and reduce risks of late-stage failures. Expert insights and case studies illustrate the impact of these methodologies on enhancing drug development processes.
Access
Visit our Content Hub, register your details to create a user profile for the hub, then login to access all content within the hub.
Content Hub Access
